Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00026247 · ClinicalTrials.gov registry record · NA

Radiofrequency Ablation in Treating Patients With Bone Metastases

A NA study, sponsored by American College of Radiology Imaging Network.

Completed
Registry status
NA
Development phase
66
Enrollment target

NCT00026247: Completed NA study, sponsored by American College of Radiology Imaging Network.

NCT00026247 is a NA study that has completed, run by American College of Radiology Imaging Network. The registered enrollment target is 66 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00026247, a NA study, has completed, sponsored by American College of Radiology Imaging Network.

COMPLETED
Registry status
NA
Development phase
66 participants
Enrollment target

Study Summary

RATIONALE: Radiofrequency ablation may be effective in decreasing pain from bone metastases. PURPOSE: Phase I/II trial to study the effectiveness of radiofrequency ablation in decreasing pain in patients who have bone metastases.

Primary Outcome

Estimate the adverse event rate due to RFA within 1 month follow-up period.

Interventions

  • PROCEDURE pain therapy
  • PROCEDURE radiofrequency ablation

Trial Details

FieldValue
Enrollment Target 66 participants
Start Date 2001-11
Est. Completion 2010-02-15
Phase NA

What the finished NCT00026247 record still lists

NCT00026247 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 66 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 2 interventions - of which pain therapy is the first listed.

NCT00026247 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00026247 about?

NCT00026247 is a clinical study titled "Radiofrequency Ablation in Treating Patients With Bone Metastases". RATIONALE: Radiofrequency ablation may be effective in decreasing pain from bone metastases. PURPOSE: Phase I/II trial to study the effectiveness of radiofrequency ablation in decreasing pain in patients who have bone metastases.

What is the current status of trial NCT00026247?

This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2001-11. Estimated completion is 2010-02-15.

What interventions are being tested in trial NCT00026247?

The interventions under investigation include: pain therapy (PROCEDURE), radiofrequency ablation (PROCEDURE).

Who is sponsoring clinical trial NCT00026247?

This trial is sponsored by American College of Radiology Imaging Network, which has 14 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00026247's enrollment target sits among peer trials

66 1139th of 2000 higher than 857 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02584244 · 66 participants · Phase 1

    Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers

  • NCT03067051 · 66 participants · Phase 1

    Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System

  • NCT03754725 · 66 participants · Phase 1

    Ferritin and Iron Burden in SAH sIRB

  • NCT03875378 · 66 participants · Phase 2

    Transdermal Estrogen in Women With Anorexia Nervosa

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00026247, the US trial registry maintained by the National Library of Medicine. NCT00026247 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.